Quality of Life and Shared Decision Making in Prostate Cancer
Socioeconomic Status, Differences in Quality of Life and Shared Decision Making Among Patients With Non-metastatic Prostate Cancer
1 other identifier
observational
10,000
1 country
1
Brief Summary
"Life after prostate cancer" is a prospective, population-based, case-control study where all men diagnosed with Prostate cancer (PCa) from 01.01.2017 regardless of age and disease stage are invited to a survey by questionnaire on their health. Men with no history of PCa are identified through the National Registry, matched on age and region of residence, and invited to the survey as controls. Patients and controls who have signed up for an official digital mailbox are invited electronically. Those who do not have a digital mailbox are invited by regular mail. All participants have given their informed consent for all linkages planned in this study. Due to electronic reporting of histological reports to the Norwegian Prostate Cancer Registry, patients are invited to the survey shortly after diagnosis. More than 6 400 patients have submitted questionnaires per April 2019.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
May 8, 2019
CompletedFirst Posted
Study publicly available on registry
May 13, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedSeptember 1, 2023
August 1, 2023
7.2 years
May 8, 2019
August 31, 2023
Conditions
Outcome Measures
Primary Outcomes (6)
Qality of life Global health status
Global health status from QLQ-C30 version 3.0 scale
3 years
Qality of life Physical functioning
Physical functioning from QLQ-C30 version 3.0 scale
3 years
Qality of life Role functioning
Role functioning from QLQ-C30 version 3.0 scale
3 years
Qality of life Emotional functioning
Emotional functioning from QLQ-C30 version 3.0 scale
3 years
Qality of life Cognitive functioning
Cognitive functioning from QLQ-C30 version 3.0 scale
3 years
Qality of life Social functioning
Social functioning from QLQ-C30 version 3.0 scale
3 years
Study Arms (2)
Prostate cancer
Men diagnosed with prostate cancer
Men without prostate cancer
Men without prostate cancer matched for age and county
Eligibility Criteria
All men with prostate cancer in Norway
You may qualify if:
- All patients diagnosed with prostate cancer in Norway at or after 01.01.2017
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Cancer Registy of Norway
Oslo, 0377, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Junior Head, Registry Dept
Study Record Dates
First Submitted
May 8, 2019
First Posted
May 13, 2019
Study Start
January 1, 2017
Primary Completion
March 31, 2024
Study Completion
December 31, 2024
Last Updated
September 1, 2023
Record last verified: 2023-08